Scientific Advisory Board

The Alzheimer's Art Quilt Initiative is most grateful for our Scientific Advisory Board whose current members are listed below. They evaluate grant proposals submitted to the AAQI so we can fund research based on scientific merit.

Michelle E. Ehrlich, M.D., is a Professor of Pediatrics, Neurology, and Genetics and Genomic Sciences at Mount Sinai School of Medicine in New York, NY. She is an expert in the creation and characterization of mouse models of neurological diseases. She created the first mouse model of Alzheimer's disease that accumulates only the most poisonous forms of protein clumps klumps known as oligomers. She is also an expert in the molecular and behavioral analyses of these mouse models.

Ali S. Faqi, DVM, PhD, DABT, is the Director of Developmental and Reproductive Toxicology and Senior Principal Study Director at MPI Research in Mattawan, Michigan. Dr. Faqi received his PhD from the University of Leipzig and his DVM from Somali National University. He earned a diploma of specialization in experimental pharmacology from the University of Milan, Italy and completed a postdoctoral fellowship at the Institute of Toxicology and Embryo Pharmacology at the Free University of Berlin, Germany. In addition to his prior industry experience at Allergan and IIT Research Institute, Dr. Faqi is also a visiting professor for the Faculty of Science, University of Palermo, Italy. "I am honored to be part of a group of volunteers devoted to such a great cause."

D. Blaine Moore, Ph.D., is an Associate Professor of Biology at Kalamazoo College. Professor Moore received his Ph.D. in Neuroscience from the University of Florida. He completed a Postdoctoral Fellowship at the Center for Neurodegenerative Disease Research at the University of Pennsylvania where he studied cellular and molecular mechanisms of Alzheimer’s disease. His current research investigates mechanisms of cell death in nervous system disease and injury states. "I am delighted to be joining AAQI’s diverse scientific advisory board and hope to help identify and fund research projects that will bring scientists closer to understanding the molecular underpinnings of this tragic disease."

Ian V.J. Murray, Ph.D., is an Assistant Professor in the Department of Neuroscience and Experimental Therapeutics at the Texas A & M Health Science Center. Dr Murray received his Ph.D. in Physiology from McGill University in Montreal, Canada. He completed his postdoctoral research at the University of Pennsylvania with Drs Paul Axelsen and Ian Blair, as well as with Drs Virginia M.-Y. Lee and John Trojanowski at the Center for Neurodegenerative Disease Research. Here he studied cellular and molecular mechanisms of Parkinson’s and Alzheimer’s diseases. His current research investigates the molecular linkage between risk factors (diabetes, Apolipoprotein E) and Alzheimer’s disease. "The AAQI has been remarkable in funding Alzheimer’s research. I am honored and delighted to join the AAQI’s diverse scientific advisory board to fund excellent research projects aimed at preventing or curing this tragic disease."

Domenico Praticò, MD, is Professor of Pharmacology, Immunology and Microbiology at Temple University, School of Medicine, Philadelphia, PA. He received his M.D. from the University of Rome - La Sapienza, where he also completed a residency program in Internal Medicine. Dr. Praticò has authored more than 185 articles, and has received many awards for his research accomplishments including the Biomedicine Investigator Award for Excellence, Neuroscience Education and Research Award, The Zenith Award from the Alzheimer’s Association. His current research focuses on molecular mechanisms underlying the early cognitive deficits of Alzheimer's disease. "I am honored and delighted to join the board and to work for such a wonderful initiative."